Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
Hagens Berman is soliciting HIMS investors for a newly filed securities class action against Hims & Hers Health and certain executives, with a class period of Aug. 4, 2025 through July 29, 2026 and a lead plaintiff deadline of Nov. 2, 2026. The suit follows the FTC's July 29, 2026 federal complaint joined by Utah and Los Angeles County, which alleges Hims shared sensitive health data with Meta and Snap via tracking pixels and billed consumers for prescriptions before any medical consultation, in alleged violation of ROSCA.
Key figures
- Class period
- Aug. 4, 2025 - July 29, 2026
- Stock drop pct
- -14.7%
- Market cap erased
- over $970 million
- Lead plaintiff deadline
- Nov. 2, 2026
- Whistleblower reward cap
- up to 30 percent of any successful SEC recovery
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.